share_log

港股公告掘金 | 科技输出收入增长迅速 变现能力大幅提升

Hong Kong Stock Announcement Nuggets | Technology export revenue is growing rapidly, and monetization capacity has increased dramatically

Zhitong Finance ·  Aug 28, 2023 19:54

[Headline announcement Nuggets]

Zhongan Online (06060) total premiums increased 37.5% year on year, profit of 221 million yuan

According to Zhitong Financial App, Zhongan Online (06060) announced its interim results for the six months ended June 30, 2023. The group obtained insurance service revenue of RMB 12.692 billion, an increase of 23.84% over the previous year; insurance service performance of 581 million yuan, an increase of 35.11%; net profit attributable to the company's shareholders was 221 million yuan, with a loss of 636 million yuan for the same period last year; basic profit of 0.15 yuan per share.

Comment:incorporationNet profit attributable to the company's shareholders was 221 million yuanThe main reasons include an improvement in investment returns and an increase in underwriting profits. In the first half of the year, premiums for the three major ecosystems of digital life, consumer finance, and automobiles all grew by more than 50% year on year. Among them, the automobile ecosystem premium had the highest increase, with a year-on-year increase of 54.3%. Among them, total premiums for new energy vehicle insurance increased by more than 228.7% year on year; digital lifestyle premiums increased by 52.8% year on year, mainly due to the increase in premiums in the return insurance and air travel business sectors. Total premiums in the consumer finance ecosystem increased by 52.0% year on year.

In terms of technology empowerment, it focuses on the integration and application of AI and insurance business, and uses technology to reshape every link in the insurance value chain. Zhongan has launched a new generation of core property insurance systems such as Wujieshan Mate and AIGC Zhongtai Lingxi to be used in all insurance links such as marketing and underwriting. Overseas market expansion: Zhongan exported technology to Home Credit, the largest consumer finance platform in Southeast Asia, and Income, a leading financial insurance company in Southeast Asia, and reached cooperation in the European market with Unika Insurance Group, one of the largest insurance groups in core markets such as Austria, Central Europe, and Eastern Europe.

[Key Announcements Nuggets]

Eagle Eye Technology-B (02251) Revenue increased 1.2 times in the first half of the year, number of service outlets, and inspection volume both increased

The Zhitong Finance App learned that Eagle Eye Technology-B (02251) announced its interim results. The company achieved revenue of 82.5 million yuan in the first half of the year, an increase of 120.6% over the previous year; gross profit of 51.36 million yuan, an increase of 132.7% over the previous year; and gross margin increased 3.3 percentage points to 62.3%.

Comment:The company's revenue growth was due to performance improvements in the company's three pillar businesses, namely Hawkeye Healthcare, Hawkeye Health, and Hawkeye Health, all of which achieved year-on-year growth. The most prominent performance is that the Hawkeye Health segment achieved revenue of 309.64 million yuan, a year-on-year increase of 307.0%. Currently, it has deployed more than 1,250 optometry centers nationwide, covering 1,371 outlets, with a year-on-year increase of more than 34.7%. The Eagle Eye Healthcare segment achieved revenue of 29.845 million yuan, an increase of 137.3% over the previous year. This is mainly due to the continued commercial release of AirDoc-aifundus (1.0), a core product used to aid in diagnosing diabetic retinopathy. The Group has sold to 143 hospitals and 525 primary care institutions. The Eagle Eye Health segment achieved revenue of RMB 21.693 million, an increase of 26.0% over the previous year. It mainly provides health risk assessment solutions focusing on chronic diseases to customer groups such as insurance companies and pharmaceutical companies. It said it is planning to further launch new businesses to build more performance growth points by combining diagnosis and treatment services for myopia, strabismus and amblyopia. Furthermore, it continues to expand its global sector layout, gradually penetrating the commercialization of products into many countries and regions such as Malaysia, Singapore, Thailand, the United Arab Emirates, and South Africa, maximizing the commercial value of products, thus driving the company's value growth.

[List of important Hong Kong stock announcements]

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment